“The team said it would normally see about one adult patient with ADEM per month at their specialist London clinic, but this had risen to at least one a week during the study period, something they described as “a concerning increase”.”
Is this really that concerning considering how many people are getting this thing? And we know covid-19 is a bit tougher on the body than your average flu. Given these two things, doesn’t it makes sense that you’re going to see some increase in a lot of rare responses to infections?
‘doesn’t it makes sense that you’re going to see some increase in a lot of rare responses to infections?’
if making sense were the basis behind covid mitigation efforts, things would certainly be different than they are now...